Related Experiment Video

Updated: Jun 27, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

Pathophysiology of atrial fibrillation: insights into the renin-angiotensin system

Jean-Yves Le Heuzey1, Eloi Marijon, Karim Chachoua

  • 1Service de cardiologie A et rythmologie, hôpital européen Georges-Pompidou, 20, rue Leblanc, 75015 Paris, France. jean-yves.le-heuzey@egp.aphp.fr

Archives of Cardiovascular Diseases
|December 9, 2008
PubMed

Insights

Atrial fibrillation poses a significant public health challenge. Blocking the renin-angiotensin system offers a promising therapeutic strategy to manage atrial fibrillation and prevent cardiovascular events.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Atrial fibrillation is a prevalent public health issue with substantial healthcare costs.
  • Current therapeutic strategies for atrial fibrillation yield suboptimal outcomes globally.
  • The renin-angiotensin system is implicated in atrial fibrillation-related cardiac remodeling.

Purpose of the Study:

  • To evaluate the role of renin-angiotensin system blockade in managing atrial fibrillation.
  • To explore the potential of these drugs in preventing cardiovascular events in atrial fibrillation patients.

Main Methods:

  • This study reviews existing literature on atrial fibrillation treatments.
  • Focus is placed on the impact of renin-angiotensin system inhibitors on patient outcomes.
  • Analysis considers the prevention of cardiovascular accidents and atrial fibrillation occurrence.

Main Results:

  • Renin-angiotensin system blockers demonstrate potential in maintaining sinus rhythm.
  • These agents are crucial for preventing cardiovascular accidents in patients with atrial fibrillation.
  • In certain cases, such as in hypertensive individuals, they may prevent the onset of atrial fibrillation.

Conclusions:

  • Therapeutic strategies for atrial fibrillation require personalized approaches, considering patient profiles.
  • Drugs targeting the renin-angiotensin system represent a valuable addition to atrial fibrillation management.
  • These medications play a key role in secondary prevention of cardiovascular events and primary prevention of atrial fibrillation in at-risk populations.
Abstract

More Related Videos

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...